Insider Trading

Notable insider buying and selling activity across public companies.

Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.

Articles

13,303 total articles

Horizon Kinetics Adds to RCG Position Amid Recent Price Appreciation

Horizon Kinetics Adds to RCG Position Amid Recent Price Appreciation

Horizon Kinetics Asset Management LLC, the investment adviser and significant shareholder of RENN Fund, Inc. (RCG), executed a purchase of 756 shares of the fund's common stock on July 1, 2026. The acquisition, valued at $2,336, brings the firm's direct holdings to 928,884 shares. This transaction follows a period of notable price appreciation for …

RGC Resources Executive Acquires Shares Through Dividend Reinvestment Plan Amid Strong Q2 Earnings

RGC Resources Executive Acquires Shares Through Dividend Reinvestment Plan Amid Strong Q2 Earnings

Lawrence T. Oliver, Senior Vice President and Secretary at RGC Resources Inc. (NASDAQ: RGCO), has acquired additional shares of the company's common stock through its Dividend Reinvestment and Stock Purchase Plan. The transaction occurred on July 1, 2026, with Mr. Oliver purchasing 12.361 shares at $24.27 per share, totaling approximately $300. Fol…

Keysight Senior Vice President Executes Pre-Arranged Stock Sale

Keysight Senior Vice President Executes Pre-Arranged Stock Sale

Ingrid A. Estrada, Senior Vice President at Keysight Technologies, Inc., executed a sale of 2,000 shares of the company's common stock on June 30, 2026. The transaction, valued at $681,740, was conducted at a price of $340.87 per share. This sale was carried out under a Rule 10b5-1 trading plan adopted by Ms. Estrada on March 30, 2026. Following th…

Cadrenal Therapeutics CEO Pham Executes Pre-Arranged Stock Sale

Cadrenal Therapeutics CEO Pham Executes Pre-Arranged Stock Sale

Pham Quang X, Chairman and CEO of Cadrenal Therapeutics, Inc. (NASDAQ:CVKD), executed a sale of 7,400 shares of common stock on June 29, 2026, resulting in gross proceeds of $22,422. The transaction was facilitated through a Rule 10b5-1 trading arrangement established on September 25, 2025. Following the divestment, Mr. Pham retains direct ownershi…

Playboy Executives Reduce Holdings Amid Stock Pressure

Playboy Executives Reduce Holdings Amid Stock Pressure

Marc Crossman, serving as both Chief Financial Officer and Chief Operating Officer at Playboy, Inc. (NASDAQ: PLBY), executed multiple share sales between late June and early July 2026. The transactions, totaling $269,968, were strictly for tax withholding purposes related to restricted stock unit settlements. This activity occurs as the company's s…